Professional
Added to YB: 2025-01-16
Pitch date: 2025-01-15
DERM [bullish]
Journey Medical Corporation
+74.8%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$177.0M
Pitch Price
$3.81
Price Target
20.00 (+210%)
Dividend
N/A
EV/EBITDA
119.72
P/E
-28.15
EV/Sales
2.60
Sector
Pharmaceuticals
Category
growth
Minot Light Capital Portfolio Holding: Journey Medical Corporation
DERM: Specialty pharma co. w/ $55-60M sales from existing portfolio. FDA approval for Emrosi (Rosacea) Nov 2024, potential $150-200M sales vs $300M for Oracea. 70% GM, no added salesforce. Trough valuation $4/share, upside $20/share (3x $150M 2027 rev or 15x $1.25 EPS). Current price $4.30, $91M mkt cap.
Read full article (2 min)